Dexmedetomidine After Cardiac Surgery for Prevention of Delirium
Status:
Recruiting
Trial end date:
2022-04-01
Target enrollment:
Participant gender:
Summary
We designed a prospective, double blind, randomized, controlled versus placebo study to
evaluate the efficacy of nightly low dose of Dexmedetomidine infusion to promote sleep and
lower delirium in a population of post cardiac surgery patients. This population is
characterized by longer ICU stay, more physical restraints such as catheters and drains, pain
and sleep deprivation. It is associated with higher prevalence of Delirium and agitation
leading to exposure to severe agitation related adverse events.
Phase:
Phase 3
Details
Lead Sponsor:
University Hospital, Brest
Collaborators:
Baxter Healthcare Corporation Direction Générale de l'Offre de Soins